Natural History and Specimen Banking for Patients with CNS Tumors
$586,749ZIAFY2018CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications & trials
Paper 39006527Paper 38737608Paper 38676932Paper 38427131Paper 38420614Paper 38281073Paper 38069666Paper 36820236Paper 36754634Paper 36741001Paper 36648507Paper 36386035Paper 35635863Paper 35601968Paper 35587280Paper 35571987Paper 35543860Paper 35542753Paper 35534067Paper 35368609Paper 35287168Paper 35191901Paper 35142534Paper 35103816Paper 34711455Paper 34160068Paper 34147576Paper 32359496Paper 32257283Paper 32096067Paper 32007210Paper 31320597Paper 31209773Paper 29500290
Abstract
This protocol is designed to meet an unmet need in neuro-oncology by evaluating patients with CNS tumors throughout their disease course. The protocol will evaluate patients with tumors of the central nervous system (CNS) who appear to be probable candidates for future protocol entry, have disease manifestations that are of unique scientific interest, importance, and/or educational value, or who have understudied tumors with unknown or unclear natural history. Patients with known genetic syndromes at high risk of developing CNS cancers will also be evaluated.
View original record on NIH RePORTER →